Skip to main content
The BMJ logoLink to The BMJ
. 1990 Oct 6;301(6755):802–804. doi: 10.1136/bmj.301.6755.802

Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.

A G Dewhurst 1, M J Cooper 1, S M Khan 1, A P Pallett 1, J R Dathan 1
PMCID: PMC1663914  PMID: 2224271

Full text

PDF
802

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisner J., Murillo J., Schimpff S. C., Steere A. C. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med. 1979 Jan;90(1):4–9. doi: 10.7326/0003-4819-90-1-4. [DOI] [PubMed] [Google Scholar]
  2. Aisner J., Wiernik P. H., Schimpff S. C. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med. 1977 May;86(5):539–543. doi: 10.7326/0003-4819-86-5-539. [DOI] [PubMed] [Google Scholar]
  3. BUTLER W. T., BENNETT J. E., ALLING D. W., WERTLAKE P. T., UTZ J. P., HILL G. J., 2nd NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. Ann Intern Med. 1964 Aug;61:175–187. doi: 10.7326/0003-4819-61-2-175. [DOI] [PubMed] [Google Scholar]
  4. Cohen J. Empirical antifungal therapy in neutropenic patients. J Antimicrob Chemother. 1984 May;13(5):409–411. doi: 10.1093/jac/13.5.409. [DOI] [PubMed] [Google Scholar]
  5. Gerson S. L., Talbot G. H., Hurwitz S., Strom B. L., Lusk E. J., Cassileth P. A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984 Mar;100(3):345–351. doi: 10.7326/0003-4819-100-3-345. [DOI] [PubMed] [Google Scholar]
  6. Gustafson T. L., Schaffner W., Lavely G. B., Stratton C. W., Johnson H. K., Hutcheson R. H., Jr Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis. 1983 Aug;148(2):230–238. doi: 10.1093/infdis/148.2.230. [DOI] [PubMed] [Google Scholar]
  7. Lentino J. R., Rosenkranz M. A., Michaels J. A., Kurup V. P., Rose H. D., Rytel M. W. Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol. 1982 Sep;116(3):430–437. doi: 10.1093/oxfordjournals.aje.a113427. [DOI] [PubMed] [Google Scholar]
  8. Marcus R. E., Goldman J. M. Management of infection in the neutropenic patient. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):406–408. doi: 10.1136/bmj.293.6544.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Meunier F. Prevention and mycoses in immunocompromised patients. Rev Infect Dis. 1987 Mar-Apr;9(2):408–416. doi: 10.1093/clinids/9.2.408. [DOI] [PubMed] [Google Scholar]
  10. Opal S. M., Asp A. A., Cannady P. B., Jr, Morse P. L., Burton L. J., Hammer P. G., 2nd Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis. 1986 Mar;153(3):634–637. doi: 10.1093/infdis/153.3.634. [DOI] [PubMed] [Google Scholar]
  11. Rhame F. S., Streifel A. J., Kersey J. H., Jr, McGlave P. B. Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med. 1984 May 15;76(5A):42–52. doi: 10.1016/0002-9343(84)90243-2. [DOI] [PubMed] [Google Scholar]
  12. Ruutu P., Valtonen V., Tiitanen L., Elonen E., Volin L., Veijalainen P., Ruutu T. An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis. 1987;19(3):347–351. doi: 10.3109/00365548709018481. [DOI] [PubMed] [Google Scholar]
  13. Sarubbi F. A., Jr, Kopf H. B., Wilson M. B., McGinnis M. R., Rutala W. A. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis. 1982 Jan;125(1):33–38. doi: 10.1164/arrd.1982.125.1.33. [DOI] [PubMed] [Google Scholar]
  14. Sherertz R. J., Belani A., Kramer B. S., Elfenbein G. J., Weiner R. S., Sullivan M. L., Thomas R. G., Samsa G. P. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med. 1987 Oct;83(4):709–718. doi: 10.1016/0002-9343(87)90902-8. [DOI] [PubMed] [Google Scholar]
  15. Tricot G., Joosten E., Boogaerts M. A., Vande Pitte J., Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis. 1987 Jan-Feb;9 (Suppl 1):S94–S99. doi: 10.1093/clinids/9.supplement_1.s94. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES